- ►mendeley.com [PDF] P Lefebvre, B Cariou, F Lien, F Kuipers, B … - Physiological …, 2009 - Am Physiological Soc The incidence of the metabolic syndrome has taken epidemic proportions in the past
decades, contributing to an increased risk of cardiovascular disease and diabetes. The metabolic
syndrome can be defined as a cluster of cardiovascular disease risk factors including ... Cited by 17 - Related articles - All 4 versions
FC Brosius - Reviews in endocrine & metabolic disorders, 2008 - Springer Abstract Progression of diabetic nephropathy (DN) is manifested by gradual scarring of both
the renal glomerulus and tubulointerstitial region. Over the past several years, the general understanding
of the pathogenic factors that lead to renal fibrosis in DN has expanded considerably. In ... Cited by 6 - Related articles - All 3 versions
Y Li, Y Qi, MS Kim, KZY Xu, THW Huang, X … - Diabetes/Metabolism … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 2 - Related articles - All 2 versions
MJ Evans, PE Mahaney, L Borges- … - American Journal of …, 2009 - Am Physiological Soc Mark J. Evans1, Paige E. Mahaney2, Lisa Borges-Marcucci1, KehDih Lai1, Shuguang
Wang1, Julie A. Krueger1, Stephen J. Gardell1, Christine Huard3, Robert Martinez3, George
P. Vlasuk1 & Douglas C. Harnish1* ... Dept of 1Cardiovascular & Metabolic Diseases, ... Cited by 3 - Related articles - All 3 versions
K Takebayashi, M Suetsugu, S Matsumoto, Y … - Southern medical …, 2009 - journals.lww.com Background: Rosuvastatin, a strong statin, and colestimide, a new anion exchange resin, are
both clinically beneficial drugs for treatment of hypercholesterolemia. The main purpose of the
study was to compare the effects of rosuvastatin and colestimide on metabolic ... Cited by 2 - Related articles - All 4 versions
A Tiwari, P Maiti - Drug Discovery Today, 2009 - Elsevier Over the past decade, new roles for bile acids in paracrine and endocrine regulation of cholesterol
homeostasis, lipid and carbohydrate metabolism and immunomodulatory functions have been
discovered. Most of the early discoveries focused on the genomic actions of bile acids ... Cited by 1 - Related articles - All 2 versions
S Zhang, J Wang, Q Liu, DC Harnish - Journal of Hepatology, 2009 - Elsevier The elevations of serum ALT and AST activities induced by the MCD diet were decreased with
WAY-362450 treatment. In terms of liver histology, while WAY-362450 treatment showed no
impact on hepatic triglyceride accumulation, it significantly reduced inflammatory cell ... Cited by 1 - Related articles - All 29 versions
S Ohtomo, Y Izuhara, M Nangaku, T Dan, S Ito, CY de … - hindawi.com Page 1. 1 [Title] Body weight control by a high-carbohydrate/low-fat diet slows the
progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic
rat model [Authors and Affiliations] Shuichi Ohtomo 1, 2 , Yuko ... View as HTML
DA Elfaki, E Bjornsson, KD Lindor - Alimentary pharmacology & …, 2009 - ncbi.nlm.nih.gov Background; The important role of nuclear receptors and their contribution to liver function in
both physiological and pathological conditions has come to attention in recent years and has
advanced our understanding of several liver diseases. These findings led to the ... Related articles
